GILEAD SCIENCES, INC. bought XLO
November 26, 2025 · Form 4 insider transaction
GILEAD SCIENCES, INC. bought 13,335,000 shares of Xilio Therapeutics, Inc. at $0.75 per share, a transaction worth $10.00M. The trade was recorded as exercise of in-the-money option and disclosed on an SEC Form 4, filed 5 days after the transaction.
Footnotes
The Reporting Person acquired 13,335,000 Prefunded Warrants upon the exercise of an equal number of Series B Warrants at an exercise price of $0.7499 per warrant. A holder of either such warrant may not exercise such warrant if, after giving effect to such exercise, the holder and its affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the outstanding shares of Common Stock of the Issuer (the "Common Stock").; The Prefunded Warrants are exercisable at any time on or after the date of issuance and have no expiration date.